↓ Skip to main content

Inhibition of lipoprotein lipid oxidation.

Overview of attention for book
Cover of 'Inhibition of lipoprotein lipid oxidation.'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Pathogenesis of Atherosclerosis
  3. Altmetric Badge
    Chapter 2 Risk Factors for Atherosclerotic Vascular Disease
  4. Altmetric Badge
    Chapter 3 Metabolic Syndrome: Therapeutic Considerations
  5. Altmetric Badge
    Chapter 4 Physical activity, obesity and cardiovascular diseases.
  6. Altmetric Badge
    Chapter 5 Fatty acids and atherosclerotic risk.
  7. Altmetric Badge
    Chapter 6 Dietary cholesterol, atherosclerosis and coronary heart disease.
  8. Altmetric Badge
    Chapter 7 Plant Sterols and Stanols
  9. Altmetric Badge
    Chapter 8 Carbohydrates and Dietary Fiber
  10. Altmetric Badge
    Chapter 9 Dietary Antioxidants and Paraoxonases Against LDL Oxidation and Atherosclerosis Development
  11. Altmetric Badge
    Chapter 10 Soy, Isoflavones and Atherosclerosis
  12. Altmetric Badge
    Chapter 11 Homocysteine and B Vitamins
  13. Altmetric Badge
    Chapter 12 Alcohol
  14. Altmetric Badge
    Chapter 13 Lipid and Non-lipid Effects of Statins
  15. Altmetric Badge
    Chapter 14 Fibrates
  16. Altmetric Badge
    Chapter 15 ACE Inhibitors and Angiotensin II Receptor Antagonists
  17. Altmetric Badge
    Chapter 16 Inhibition of Platelet Activation and Aggregation
  18. Altmetric Badge
    Chapter 17 The ABC of Hepatic and Intestinal Cholesterol Transport
  19. Altmetric Badge
    Chapter 18 Inhibition of the Synthesis of Apolipoprotein B-Containing Lipoproteins
  20. Altmetric Badge
    Chapter 19 Therapy of Hyper-Lp(a)
  21. Altmetric Badge
    Chapter 20 Modulation of High-Density Lipoprotein Cholesterol Metabolism and Reverse Cholesterol Transport
  22. Altmetric Badge
    Chapter 21 Inhibition of Lipoprotein Lipid Oxidation
  23. Altmetric Badge
    Chapter 22 Correction of Insulin Resistance and the Metabolic Syndrome
  24. Altmetric Badge
    Chapter 23 Protection of Endothelial Function
  25. Altmetric Badge
    Chapter 24 Modulation of Smooth Muscle Cell Proliferation and Migration: Role of Smooth Muscle Cell Heterogeneity
  26. Altmetric Badge
    Chapter 25 Modulation of Macrophage Function and Metabolism
  27. Altmetric Badge
    Chapter 26 Inflammation Is a Crucial Feature of Atherosclerosis and a Potential Target to Reduce Cardiovascular Events
  28. Altmetric Badge
    Chapter 27 Autoimmune Mechanisms of Atherosclerosis
  29. Altmetric Badge
    Chapter 28 Drug Therapies to Prevent Coronary Plaque Rupture and Erosion: Present and Future
  30. Altmetric Badge
    Chapter 29 Reciprocal Role of Vasculogenic Factors and Progenitor Cells in Atherogenesis
  31. Altmetric Badge
    Chapter 30 Gene Therapy of Atherosclerosis
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 707)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
8 news outlets
blogs
3 blogs
policy
1 policy source
twitter
17 X users
facebook
3 Facebook pages
wikipedia
18 Wikipedia pages
googleplus
4 Google+ users
video
6 YouTube creators

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibition of lipoprotein lipid oxidation.
Published by
Handbook of experimental pharmacology, January 2005
DOI 10.1007/3-540-27661-0-21
Pubmed ID
ISBNs
978-3-54-022569-0, 978-3-54-027661-6
Authors

Cynshi, O, Stocker, R

Editors

Professor Dr. med. Arnold von Eckardstein

Abstract

According to the oxidative modification hypothesis, antioxidants that inhibit the oxidation of low-density lipoprotein (LDL) are expected to attenuate atherosclerosis, yet not all antioxidants that inhibit LDL oxidation in vitro inhibit disease in animal models of atherosclerosis. As with animal studies, a benefit with dietary supplements of antioxidants in general and vitamin E in particular was anticipated in humans, yet the overall outcome of large, randomized controlled studies has been disappointing. However, in recent years it has become clear that the role of vitamin E in LDL oxidation and the relationship between in vitro and in vivo inhibition of LDL oxidation are more complex than previously appreciated, and that oxidative events in addition to LDL oxidation in the extracellular space need to be considered in the context of an antioxidant as a therapeutic drug against atherosclerosis. This review focuses on some of these complexities, proposes a novel method to assess in vitro 'oxidizability' of lipoprotein lipids, and summarizes the present situation of development of antioxidant compounds as drugs against atherosclerosis and related cardiovascular disorders.

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 50%
Professor > Associate Professor 1 25%
Student > Postgraduate 1 25%
Student > Master 1 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 50%
Chemistry 1 25%
Medicine and Dentistry 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 115. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2024.
All research outputs
#371,081
of 26,017,215 outputs
Outputs from Handbook of experimental pharmacology
#15
of 707 outputs
Outputs of similar age
#582
of 155,260 outputs
Outputs of similar age from Handbook of experimental pharmacology
#2
of 12 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 707 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,260 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.